Overview
SCIENTIFIC SCORE
Possibly Effective
Based on 21 Researches
7.5
USERS' SCORE
Good
Based on 2 Reviews
8.2
Supplement Facts
Serving Size: 2 Soft Gels
Amount Per Serving
%DV
Calories
30
Total Fat
2.5 g
3%**
Cholesterol
<5 mg
1%
Protein
<1 g
Vitamin E (as natural d-alpha tocopherol)
13.4 mg
89%
Norwegian Fish Oil
2.5 g
â€
Total Omega-3 Fatty Acids*
1,600 mg
â€
EPA (Eicosapentaenoic Acid)*
800 mg
â€
DHA (Docosahexaenoic Acid)*
600 mg
â€
Top Medical Research Studies
9
We delved into the potential of omega-3 polyunsaturated fatty acids, specifically docosahexaenoic acid (DHA), to combat glioblastoma, one of the most aggressive brain tumors.
In our study, we found that DHA treatment led to cell death in glioblastoma cells, as evidenced by signs of apoptosis and increased autophagy. Furthermore, tests in transgenic mice revealed a notable reduction in tumor size and increased activity reflected in cell death markers.
While these findings suggest a promising avenue for GBM treatment, further research is needed to fully understand how omega-3 fatty acids could be integrated into cancer therapies.
In our study, we found that DHA treatment led to cell death in glioblastoma cells, as evidenced by signs of apoptosis and increased autophagy. Furthermore, tests in transgenic mice revealed a notable reduction in tumor size and increased activity reflected in cell death markers.
While these findings suggest a promising avenue for GBM treatment, further research is needed to fully understand how omega-3 fatty acids could be integrated into cancer therapies.
Read More
8
We investigated the potential of docosahexaenoic acid (DHA) liposomes in treating glioblastoma, a challenging type of brain tumor. Using an advanced microfluidic system, we created liposomes that effectively penetrated GBM cells.
The results were promising; the DHA liposomes not only reduced tumor cell viability but also initiated cell death more effectively than regular DHA. This study opens new avenues for cancer treatment using omega-3 fatty acids in liposome formulations, highlighting their potential as a valuable therapeutic strategy.
The results were promising; the DHA liposomes not only reduced tumor cell viability but also initiated cell death more effectively than regular DHA. This study opens new avenues for cancer treatment using omega-3 fatty acids in liposome formulations, highlighting their potential as a valuable therapeutic strategy.
Read More
7
We analyzed data from nine observational studies to better understand the connection between fish consumption and brain tumor risk. Our findings suggest that increasing fish intake may be linked to a 17% lower risk of developing brain cancer, with a notable dose-response relationship.
However, we also emphasize the need for further research, including well-designed cohort studies, to confirm these initial results and clarify any potential confounding factors.
However, we also emphasize the need for further research, including well-designed cohort studies, to confirm these initial results and clarify any potential confounding factors.
Read More
Most Useful Reviews
6
Supports brain health
Elite Omega 3 is a high-quality supplement containing Omega-3 fatty acids that support heart, joint, and brain health. It absorbs easily and aids in improving overall tone and immunity.
Read More
7.5
Enhances brain immunity
Favourite Omega DHA is crucial for brain health, aiding in the formation of strong immunity, managing overexcitement and nervous tension, and improving vision. Store the supplement in the refrigerator and use it regularly. Avoid keeping Omega-3 preparations for over two months. It's essential to take it if platelets remain above 200, as Omega thins the blood. The usual course lasts three months. It boasts excellent quality, convenient packaging, and a reasonable price for such quality!
Read More
Medical Researches
SCIENTIFIC SCORE
Possibly Effective
Based on 21 Researches
7.5
- All Researches
9
We delved into the potential of omega-3 polyunsaturated fatty acids, specifically docosahexaenoic acid (DHA), to combat glioblastoma, one of the most aggressive brain tumors.
In our study, we found that DHA treatment led to cell death in glioblastoma cells, as evidenced by signs of apoptosis and increased autophagy. Furthermore, tests in transgenic mice revealed a notable reduction in tumor size and increased activity reflected in cell death markers.
While these findings suggest a promising avenue for GBM treatment, further research is needed to fully understand how omega-3 fatty acids could be integrated into cancer therapies.
In our study, we found that DHA treatment led to cell death in glioblastoma cells, as evidenced by signs of apoptosis and increased autophagy. Furthermore, tests in transgenic mice revealed a notable reduction in tumor size and increased activity reflected in cell death markers.
While these findings suggest a promising avenue for GBM treatment, further research is needed to fully understand how omega-3 fatty acids could be integrated into cancer therapies.
Read More
9
We investigated the effects of eicosapentaenoic acid (EPA) alongside docosahexaenoic acid (DHA) on medulloblastoma, a common and aggressive brain tumor in children.
In our study, we treated medulloblastoma cell lines with these omega-3 fatty acids and observed notable changes. Both EPA and DHA significantly reduced the production of prostaglandin E2, a compound associated with tumor growth and inflammation. Furthermore, we saw that these treatments impaired the viability of medulloblastoma cells, meaning fewer cancer cells were able to survive and grow. Additionally, the treatment led to increased cell death and reduced the ability of these cells to form colonies.
When we moved to the in vivo part of our study, where we implanted human medulloblastoma cells into mice, the results were promising. Mice treated with DHA, with or without EPA, experienced reduced tumor growth. Notably, levels of prostaglandin E and another compound, prostacyclin, dropped significantly in the tumors of treated animals compared to those that did not receive treatment. This suggests that the omega-3 fatty acids helped create a less favorable environment for tumor growth.
Our analysis uncovered that the treatment led to a downregulation of several key genes, with CRYAB being the most significantly affected. We confirmed this finding via various techniques, including immunohistochemistry. This research hints at the potential of combining DHA and EPA in existing treatment plans to target inflammation specific to the tumor environment.
In our study, we treated medulloblastoma cell lines with these omega-3 fatty acids and observed notable changes. Both EPA and DHA significantly reduced the production of prostaglandin E2, a compound associated with tumor growth and inflammation. Furthermore, we saw that these treatments impaired the viability of medulloblastoma cells, meaning fewer cancer cells were able to survive and grow. Additionally, the treatment led to increased cell death and reduced the ability of these cells to form colonies.
When we moved to the in vivo part of our study, where we implanted human medulloblastoma cells into mice, the results were promising. Mice treated with DHA, with or without EPA, experienced reduced tumor growth. Notably, levels of prostaglandin E and another compound, prostacyclin, dropped significantly in the tumors of treated animals compared to those that did not receive treatment. This suggests that the omega-3 fatty acids helped create a less favorable environment for tumor growth.
Our analysis uncovered that the treatment led to a downregulation of several key genes, with CRYAB being the most significantly affected. We confirmed this finding via various techniques, including immunohistochemistry. This research hints at the potential of combining DHA and EPA in existing treatment plans to target inflammation specific to the tumor environment.
Read More
9
We investigated the potential of docosahexaenoic acid (DHA) as part of a novel treatment for glioblastoma, a challenging brain tumor. Our study involved formulating mebendazole (MBZ) microemulsions that included DHA along with other compounds, assessing their effectiveness in an orthotopic C6 rat model.
The formulations were carefully characterized before testing. We found that one formulation—composed of oleic acid and labrafil, with a 0.1% mucoadhesive agent—showed promising results. Importantly, there were no observable toxic effects on the nasal epithelium, suggesting the safety of this delivery method.
Furthermore, we observed improved survival rates in the treated rats compared to the control group. Our findings implied that this combined approach with DHA and MBZ microemulsions might offer a new avenue for glioblastoma treatment, although we noted that the contribution of DHA alone couldn't be fully isolated.
Overall, our research encourages the exploration of innovative strategies to enhance the treatment of malignant brain tumors through targeted intranasal delivery.
The formulations were carefully characterized before testing. We found that one formulation—composed of oleic acid and labrafil, with a 0.1% mucoadhesive agent—showed promising results. Importantly, there were no observable toxic effects on the nasal epithelium, suggesting the safety of this delivery method.
Furthermore, we observed improved survival rates in the treated rats compared to the control group. Our findings implied that this combined approach with DHA and MBZ microemulsions might offer a new avenue for glioblastoma treatment, although we noted that the contribution of DHA alone couldn't be fully isolated.
Overall, our research encourages the exploration of innovative strategies to enhance the treatment of malignant brain tumors through targeted intranasal delivery.
Read More
8
We investigated the potential of docosahexaenoic acid (DHA) liposomes in treating glioblastoma, a challenging type of brain tumor. Using an advanced microfluidic system, we created liposomes that effectively penetrated GBM cells.
The results were promising; the DHA liposomes not only reduced tumor cell viability but also initiated cell death more effectively than regular DHA. This study opens new avenues for cancer treatment using omega-3 fatty acids in liposome formulations, highlighting their potential as a valuable therapeutic strategy.
The results were promising; the DHA liposomes not only reduced tumor cell viability but also initiated cell death more effectively than regular DHA. This study opens new avenues for cancer treatment using omega-3 fatty acids in liposome formulations, highlighting their potential as a valuable therapeutic strategy.
Read More
8
We explored the potential of omega-3 fatty acid, docosahexaenoic acid (DHA), to combat glioblastoma, an aggressive brain tumor. By studying patient-derived GBM neural stem-like cells, we found that DHA treatment increases its levels in these cells, assisted by a protein called FABP7. This increase in DHA was linked to a reduction in the cells' ability to migrate, suggesting a possible therapeutic approach to limit tumor spread. However, more research is needed to fully understand the implications of DHA on glioblastoma treatment.
Read More
User Reviews
USERS' SCORE
Good
Based on 2 Reviews
8.2
- All Reviews
- Positive Reviews
- Negative Reviews
6
Supports brain health
Elite Omega 3 is a high-quality supplement containing Omega-3 fatty acids that support heart, joint, and brain health. It absorbs easily and aids in improving overall tone and immunity.
Read More
7.5
Enhances brain immunity
Favourite Omega DHA is crucial for brain health, aiding in the formation of strong immunity, managing overexcitement and nervous tension, and improving vision. Store the supplement in the refrigerator and use it regularly. Avoid keeping Omega-3 preparations for over two months. It's essential to take it if platelets remain above 200, as Omega thins the blood. The usual course lasts three months. It boasts excellent quality, convenient packaging, and a reasonable price for such quality!
Read More
Frequently Asked Questions
No FAQs are available for this product and symptom.
References
- Mendanha D, Casanova MR, Gimondi S, Ferreira H, Neves NM. Microfluidic-Derived Docosahexaenoic Acid Liposomes for Targeting Glioblastoma and Its Inflammatory Microenvironment. ACS Appl Mater Interfaces. 2024;16:40543. doi:10.1021/acsami.4c01368
- Mendanha D, Gimondi S, Costa BM, Ferreira H, Neves NM. Microfluidic-derived docosahexaenoic acid liposomes for glioblastoma therapy. Nanomedicine. 2023;53:102704. doi:10.1016/j.nano.2023.102704
- Öcal Ö, Nazıroğlu M. Eicosapentaenoic acid enhanced apoptotic and oxidant effects of cisplatin via activation of TRPM2 channel in brain tumor cells. Chem Biol Interact. 2022;359:109914. doi:10.1016/j.cbi.2022.109914
- Choi WS, Xu X, Goruk S, Wang Y, Patel S, et al. FABP7 Facilitates Uptake of Docosahexaenoic Acid in Glioblastoma Neural Stem-like Cells. Nutrients. 2021;13. doi:10.3390/nu13082664
- Yan CH, Rathor A, Krook K, Ma Y, Rotella MR, et al. Effect of Omega-3 Supplementation in Patients With Smell Dysfunction Following Endoscopic Sellar and Parasellar Tumor Resection: A Multicenter Prospective Randomized Controlled Trial. Neurosurgery. 2020;87:E91. doi:10.1093/neuros/nyz559
- Kim S, Jing K, Shin S, Jeong S, Han SH, et al. ω3-polyunsaturated fatty acids induce cell death through apoptosis and autophagy in glioblastoma cells: In vitro and in vivo. Oncol Rep. 2018;39:239. doi:10.3892/or.2017.6101
- Shinde RL, Devarajan PV. Docosahexaenoic acid-mediated, targeted and sustained brain delivery of curcumin microemulsion. Drug Deliv. 2017;24:152. doi:10.1080/10717544.2016.1233593
- Lian W, Wang R, Xing B, Yao Y. Fish intake and the risk of brain tumor: a meta-analysis with systematic review. Nutr J. 2017;16:1. doi:10.1186/s12937-016-0223-4
- Harvey KA, Xu Z, Saaddatzadeh MR, Wang H, Pollok K, et al. Enhanced anticancer properties of lomustine in conjunction with docosahexaenoic acid in glioblastoma cell lines. J Neurosurg. 2015;122:547. doi:10.3171/2014.10.JNS14759
- Wang F, Bhat K, Doucette M, Zhou S, Gu Y, et al. Docosahexaenoic acid (DHA) sensitizes brain tumor cells to etoposide-induced apoptosis. Curr Mol Med. 2011;11:503.
- Cui PH, Petrovic N, Murray M. The ω-3 epoxide of eicosapentaenoic acid inhibits endothelial cell proliferation by p38 MAP kinase activation and cyclin D1/CDK4 down-regulation. Br J Pharmacol. 2011;162:1143. doi:10.1111/j.1476-5381.2010.01113.x
- Nasrollahzadeh J, Siassi F, Doosti M, Eshraghian MR, Shokri F, et al. The influence of feeding linoleic, gamma-linolenic and docosahexaenoic acid rich oils on rat brain tumor fatty acids composition and fatty acid binding protein 7 mRNA expression. Lipids Health Dis. 2008;7:45. doi:10.1186/1476-511X-7-45
- Denkins Y, Kempf D, Ferniz M, Nileshwar S, Marchetti D. Role of omega-3 polyunsaturated fatty acids on cyclooxygenase-2 metabolism in brain-metastatic melanoma. J Lipid Res. 2005;46:1278.
- Gramaglia A, Loi GF, Mongioj V, Baronzio GF. Increased survival in brain metastatic patients treated with stereotactic radiotherapy, omega three fatty acids and bioflavonoids. Anticancer Res. 1999;19:5583.
- Ljungblad L, Bergqvist F, Tümmler C, Madawala S, Olsen TK, et al. Omega-3 fatty acids decrease CRYAB, production of oncogenic prostaglandin E and suppress tumor growth in medulloblastoma. Life Sci. 2022;295:120394. doi:10.1016/j.lfs.2022.120394
- Yuan Y, Shah N, Almohaisin MI, Saha S, Lu F. Assessing fatty acid-induced lipotoxicity and its therapeutic potential in glioblastoma using stimulated Raman microscopy. Sci Rep. 2021;11:7422. doi:10.1038/s41598-021-86789-9
- Salvati S, Natali F, Attorri L, Raggi C, Di Biase A, et al. Stimulation of myelin proteolipid protein gene expression by eicosapentaenoic acid in C6 glioma cells. Neurochem Int. 2004;44:331.
- Leaver HA, Bell HS, Rizzo MT, Ironside JW, Gregor A, et al. Antitumour and pro-apoptotic actions of highly unsaturated fatty acids in glioma. Prostaglandins Leukot Essent Fatty Acids. 2002;66:19.
- Xu X, Wang Y, Choi WS, Sun X, Godbout R. Super resolution microscopy reveals DHA-dependent alterations in glioblastoma membrane remodelling and cell migration. Nanoscale. 2021;13:9706. doi:10.1039/d1nr02128a
- Mena-Hernández J, Jung-Cook H, Llaguno-Munive M, GarcÃa-López P, Ganem-Rondero A, et al. Preparation and Evaluation of Mebendazole Microemulsion for Intranasal Delivery: an Alternative Approach for Glioblastoma Treatment. AAPS PharmSciTech. 2020;21:264. doi:10.1208/s12249-020-01805-x
- Tan X, Zou L, Qin J, Xia D, Zhou Y, et al. SQSTM1/p62 is involved in docosahexaenoic acid-induced cellular autophagy in glioblastoma cell lines. In Vitro Cell Dev Biol Anim. 2019;55:703. doi:10.1007/s11626-019-00387-8
